Ragamac, Reyvin .

HRN: 25-99-83  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/14/2024
12/21/2024
IV
2.2g
Q6hours
Presumptive PTB
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: